Paradigm Biopharmaceuticals Limited Stock
Stocks
PAR
AU000000PAR5
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Australian S.E.
09:10:26 18/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.2450 AUD | -2.00% |
|
-.--% | -27.94% |
| 10-09 | Paradigm Biopharmaceuticals Flags Missing Trial Data, Maintains Trading Suspension | MT |
| 10-08 | Paradigm Biopharmaceuticals Limited Provides Update on the Phase 3 Data | CI |
| Market Cap | 153M 104M 94.46M 87.26M 78.84M 149M 9.82B 1.05B 416M 5.26B 392M 384M 16.7B | P/E 2027 * |
-2.95x | P/E 2028 * | 1.35x |
|---|---|---|---|---|---|
| Enterprise Value | 141M 96.28M 87.08M 80.44M 72.68M 137M 9.06B 964M 384M 4.85B 361M 354M 15.39B | EV / Sales 2027 * |
-
| EV / Sales 2028 * | -0.33x |
| Free-Float |
91.79% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| PAR | Delayed | |
OTC Markets
| PBIGF | Delayed | |
|
Deutsche Boerse AG
| P86 | Delayed | |
|
Börse Stuttgart
| P86 | Delayed |
| 1 day | -2.00% | ||
| 3 months | +36.11% | ||
| 6 months | +40.00% | ||
| Current year | -27.94% |
| Current year | 0.14 |  | 0.37 |
| 1 year | 0.14 | | 0.39 |
| 3 years | 0.14 | | 0.66 |
| 5 years | 0.14 | | 2.33 |
| 10 years | 0.14 | | 4.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul Rennie
CEO | Chief Executive Officer | - | 22/11/2022 |
| Director of Finance/CFO | - | 03/03/2023 | |
| Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Rennie
CHM | Chairman | - | - |
Amos Meltzer
BRD | Director/Board Member | 60 | 09/12/2020 |
Matthew Fry
BRD | Director/Board Member | - | 04/03/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/2/26 A | Buy | Chief Executive Officer | 176,470 | 0.0336% | ||
| 6/2/26 A | Buy | Chief Executive Officer | 176,470 | 0.0336% | ||
| 6/2/26 A | Buy | Chief Executive Officer | 176,470 | 0.0336% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.00% | -.--% | -37.18% | -36.36% | 105M | |
| +1.10% | +1.03% | +62.53% | +70.47% | 67.53B | |
| +1.28% | +8.79% | +16.26% | +95.16% | 60.74B | |
| +0.36% | +0.67% | +20.48% | +99.04% | 55.66B | |
| -0.96% | +10.11% | +21.04% | +108.91% | 47.97B | |
| -1.25% | +2.77% | +24.06% | +38.34% | 45.24B | |
| -2.41% | -11.69% | +175.20% | +794.72% | 39.08B | |
| +1.21% | +4.75% | +27.30% | +52.81% | 35.34B | |
| -0.87% | -1.34% | +83.95% | +63.96% | 33.45B | |
| -2.22% | +7.34% | -39.04% | +397.14% | 26.49B | |
| Average | -0.58% | +2.64% | +35.46% | +168.42% | 41B | |
| Weighted average by Cap. | -0.17% | +2.88% | +43.80% | +166.64% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | 322M 219M 198M 183M 165M 312M 20.6B 2.19B 873M 11.03B 822M 805M 35.02B |
| Net income | -44.8M -30.49M -27.57M -25.47M -23.01M -43.47M -2.87B -305M -121M -1.53B -114M -112M -4.87B | 99.5M 67.71M 61.24M 56.57M 51.11M 96.54M 6.37B 678M 270M 3.41B 254M 249M 10.82B |
| Net Debt | -12M -8.17M -7.39M -6.82M -6.16M -11.64M -768M -81.8M -32.54M -411M -30.65M -30M -1.31B | -260M -177M -160M -148M -134M -252M -16.64B -1.77B -705M -8.91B -664M -650M -28.28B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- PAR Stock
Select your edition
All financial news and data tailored to specific country editions
